AOAC Extends Approval of Life Technologies’ Salmonella Detection Kit to Include Environmental Surfaces
by Mauricio Minotta - 01/24/11
CARLSBAD, Calif. – Jan. 24, 2011 – Life Technologies Corporation today announced that the AOAC Research Institute has extended approval of the Applied Biosystems MicroSEQ® Salmonella spp. Detection Kit for use on environmental surfaces at processing plants where food products are handled and packaged. In addition to facilitating accurate detection of Salmonella in food samples, the validated PCR-based tool can also now provide a means for implementing effective measures to prevent contamination.
Previously approved for use with 11 different food sample types, including raw ground beef, chicken, shrimp, dry pet food, spinach and peanut butter, the latter two of which being the cause of wide-spread Salmonella outbreaks in recent years, the MicroSEQ Salmonella spp. Detection Kit has now also received the AOAC’s highly coveted Performance Tested Methods certification for use on surfaces such as stainless steel, plastic, ceramic tile, sealed concrete and rubber.
“Testing of the food plant environment is equally, if not more, important as testing the products themselves to ensure the safety of our food supply,” said Dr. Sharon Brunelle, technical consultant for the AOAC Research Institute. “The need for validated tools to help producers take preventative measures has also become an important issue in this country. Life Technologies demonstrated that its MicroSEQ Salmonella spp. Detection Kit performed as well or better than the Food and Drug Administration’s Bacteriological Analytical Manual method for testing of various environmental surfaces.”
The Food Safety Modernization Act (FSMA) passed by Congress on Dec. 21, 2010 calls for federal regulators to implement prevention-based controls, rather than responding to contaminations. There are at least 40,000 cases of Salmonella poisoning each year, according to the U.S. Centers for Disease Control and Prevention. The bacterium can contaminate a wide variety of foods including meats, poultry, dairy products, eggs, fruits and vegetables, even during and after processing. The most recent outbreak sickened at least 2,000 people prompting the recall of more than 550 million eggs in the summer of 2010.
“With U.S. legislation now focused on preventing outbreaks rather than simply detecting foodborne pathogens that cause them, our universal molecular solution enables food producers to proactively monitor their facilities before Salmonella contaminates their products,” says Nir Nimrodi, General Manager of the Animal and Food Safety Business for Life Technologies. “Validation of our detection kit for this type of testing is aligned with our strategic goal to support our customers by increasing their confidence in the safety of their products.”
Last fall, the MicroSEQ Salmonella spp. Detection Kit also received AFNOR certification, affirming the test meets the organization’s stringent standards (EN ISO 16140) that are set for international markets.
The kit is part of a complete pathogen detection workflow based on proven Applied Biosystems technology, and optimized for use with the Applied Biosystems 7500 Fast Real-Time PCR System. The rapid test requires only small amounts of sample to ensure detection of Salmonella in less than 18 hours, as compared to several days with conventional methods. It includes options for low and high-throughput sample preparation and streamlined data analysis software.
The AOAC Research Institute focuses on the development, use, and harmonization of validated analytical methods and its validation is important for food safety. The certification of the MicroSEQ Salmonella spp. Detection Kit means that the assay meets the stringent pathogen detection requirements of many companies and testing organizations responsible for safeguarding food supplies.
For research use only. Not for use in diagnostic procedures.
About Life Technologies (www.lifetechnologies.com)
Life Technologies Corporation is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in approximately 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.
Life Technologies’ Safe Harbor Statement
This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies’ plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
Life Technologies Contact